| scholarly article | Q13442814 |
| P2093 | author name string | Sanjay Awasthi | |
| Sharad S Singhal | |||
| Jyotsana Singhal | |||
| Lokesh Nagaprashantha | |||
| Shireen Chikara | |||
| David Horne | |||
| P2860 | cites work | Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin | Q22254720 |
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Q28283241 | ||
| Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity | Q28285710 | ||
| Vascular-specific growth factors and blood vessel formation | Q29614780 | ||
| Significance of immunohistochemistry in breast cancer | Q34023682 | ||
| The role of vascular endothelial growth factor in angiogenesis | Q34111713 | ||
| Citrus fruit intake and breast cancer risk: a quantitative systematic review | Q34339770 | ||
| Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies | Q34562896 | ||
| Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis. | Q34729947 | ||
| 2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma | Q34734139 | ||
| Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance | Q35179100 | ||
| Natural products as sources of new drugs over the period 1981-2002. | Q35184693 | ||
| The Bcl-2 family: roles in cell survival and oncogenesis. | Q35591695 | ||
| MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway | Q35854037 | ||
| Vascular and anti-oxidant actions of flavonols and flavones. | Q35964813 | ||
| Molecular classification and molecular forecasting of breast cancer: ready for clinical application? | Q36250255 | ||
| RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization | Q36322720 | ||
| SR4 Uncouples Mitochondrial Oxidative Phosphorylation, Modulates AMP-dependent Kinase (AMPK)-Mammalian Target of Rapamycin (mTOR) Signaling, and Inhibits Proliferation of HepG2 Hepatocarcinoma Cells. | Q36381908 | ||
| Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer | Q36495792 | ||
| Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be t | Q36610188 | ||
| Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1 | Q36744205 | ||
| Primary extraosseous Ewing sarcoma of the lung in children | Q36791086 | ||
| Breast cancer brain metastases: new directions in systemic therapy | Q36822500 | ||
| Signal transduction and molecular targets of selected flavonoids | Q36945980 | ||
| Optical imaging of the breast | Q36990563 | ||
| RLIP76 in defense of radiation poisoning | Q37146998 | ||
| Regression of prostate cancer xenografts by RLIP76 depletion | Q37194622 | ||
| RLIP76 and Cancer | Q37217140 | ||
| Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer. | Q37298918 | ||
| Triple negative breast cancers: clinical and prognostic implications. | Q37602289 | ||
| Regression of melanoma in a murine model by RLIP76 depletion | Q38315672 | ||
| Targeting p53-null neuroblastomas through RLIP76. | Q38336615 | ||
| RLIP76: a target for kidney cancer therapy | Q39856444 | ||
| Mitogenic and drug-resistance mediating effects of PKCalpha require RLIP76. | Q40247154 | ||
| The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer | Q40387322 | ||
| Breast cancer: cause and prevention | Q40415946 | ||
| Reproductive factors and breast cancer | Q40862181 | ||
| The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity | Q41566049 | ||
| First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial | Q44146948 | ||
| Temporal trends in breast cancer mortality by state and race | Q50135770 | ||
| Epidemiology and prevention of breast cancer | Q71303982 | ||
| Inhibition of mammary cancer by citrus flavonoids | Q77440730 | ||
| Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1) | Q80274383 | ||
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 75025-75037 | |
| P577 | publication date | 2017-08-24 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | 2'-Hydroxyflavanone: A novel strategy for targeting breast cancer | |
| P478 | volume | 8 |
| Q55312006 | 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer. |
| Q59799450 | Anticancer activity of 2'-hydroxyflavanone towards lung cancer |
| Q88130217 | Food Additive Sodium Benzoate (NaB) Activates NFκB and Induces Apoptosis in HCT116 Cells |
| Q52724571 | Rlip depletion prevents spontaneous neoplasia in TP53 null mice. |
| Q90724875 | Topical 2'-Hydroxyflavanone for Cutaneous Melanoma |
| Q47567895 | Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer |
Search more.